Development of a 5-HT7 receptor antibody for the rat: the good, the bad, and the ugly
-
Published:2023-04-18
Issue:10
Volume:396
Page:2599-2611
-
ISSN:0028-1298
-
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
-
language:en
-
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol
Author:
Thompson Janice M., Tragge Will, Flood Emma D., Schulz Stefan, Lisabeth Erika, Watts Stephanie W.ORCID
Abstract
AbstractOur laboratory has a vested interest in measuring the location and expression of the 5-hydroxytryptamine (5-HT, serotonin) 7 (5-HT7) receptor in the rat. Determining tissue-specific receptor expression would aid in validating understood and potentially new tissues that support the 5-HT7 receptor-mediated fall in blood pressure, an event we are committed to understand. We contracted with 7TM Antibodies to develop deliberately and rigorously a rat 5-HT7 (r5-HT7) receptor specific antibody. Three antigens, two targeting the third internal loop and one the C terminus, were used in three rabbits to generate antibodies. As a positive control, HEK293(T or AD) cells were transfected with a plasmid for the r5-HT7 receptor also expressing a C terminus 3xFLAG tag. Naïve rat tissues were also used in Western and immunohistochemical analyses. Nine antibodies (3 from three different rabbits) detected a ~ 75 kDa protein absent in homogenates of vector control HEK293T cells. Only antibodies that recognized the C terminus of the 5-HT7 receptor [ERPERSEFVLQNSDH(Abu)GKKGHDT; antibodies 3, 6, and 9] positively and concentration-dependently identified the r5-HT7 receptor expressed in Westerns of transfected HEK293T cells. These same C terminus antibodies also successfully detected the r5-HT7 receptor in immunocytochemical test of the transfected HEK293AD cells, colocalizing with the detected FLAG sequence. In naive tissue, antibody 6 performed the best, identifying specific bands in the brain cortex in Western analysis. These same antibodies produced a more diverse band profile in the vena cava, identifying 6 major proteins. In immunohistochemical experiments, the same C-terminus antibodies, with antibody 3 performing the best, detected the 5-HT7 receptor in rat veins. This deliberate work has given rise to at least three antibodies that can be used with good confidence in r5-HT7 transfected cells, two antibodies that can be used in immunohistochemical analyses of rat tissues and in Westerns of rat brain; we are less confident of the use of these same antibodies in rat veins.
Funder
National Heart, Lung, and Blood Institute
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference27 articles.
1. Barnes NM, Ahern GP, Becamel Bockaert CJ, Camilleri C, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D (2021) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine Pharmacology and Function. Pharmacol Rev 73(1):310–520 2. Blattner KM, Canney DJ, Pippin DA, Blass EB (2019) Pharmacology and therapeutic potential of the 5-HT7 receptor. ACS Chem Neurosci 10:89–119 3. Cinar I, Sirin B, Halici Z, Palabiyik-Yucelik SS, Akpinar E, Cadirci E (2021) 5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissues. Naunyn Schmiedebergs Arch Pharmacol 394:1205–1213 4. Demireva EY, Xie H, Darios ES, Thompson JM, Seitz B, Watts SW (2019) Creation of the 5-Hydroxytryptamine receptor 7 knockout (Htr7 KO) rat as a tool for cardiovascular research. Physiol Genomics 51(7):302–310 5. Diaz J, Ni W, King A, Fink GD, Watts SW (2008) 5-hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther 325:1031–1038
|
|